‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌   ‌
 
 

MULTIDISCIPLINARY TEAMS ARE BEGINNING TO PLAN FOR RESTART OF UIC RESEARCH OPERATIONS WHEN CONDITIONS ALLOW. 

INFORMATION ON RESEARCH RESTART AND UIC PLANS FOR THE 'ROAD TO RECOVERY' CAN BE FOUND ON THE UIC MAIN PAGE; UPDATED INFORMATION ON RESEARCH RECOVERY PLANS WILL BE PROVIDED ON THIS  OVCR PAGE AS IT BECOMES AVAILABLE. 

UPDATED INFORMATION ON OVCR COVID-19 RELATED OPERATIONS, NEWS & ANNOUNCEMENTS CAN BE FOUND ON THE OVCR MAIN PAGE.

SCHOOL OF PUBLIC HEALTH WEBSITE ALSO PROVIDES COVID -19 INFORMATION AND RESOURCES

COVID-19 FUNDING ANNOUNCEMENTS 

Vinnova: Innovations to Mitigate the Crisis
Funding amount: varies
Application deadline: May 29, 2020
Vinnova is calling on innovative ideas to address the wider impact of the corona crisis. We want to attract projects that support our society in a challenging time. New solutions should be ready to be put into practice within six to twelve months.

Robert Wood Johnson Foundation (RWJF) Emergency Response for the HealthCare System: Phase I/a
Funding amount: unspecified
Application deadline: June 12, 2020, by 11:59 pm ET (Phase I Deadline:); August 18, 2020, by 11:59 pm ET (Phase II Deadline)
Can you create a digital tool supporting the health care system (including but not limited to providers, government, and public health and community organizations) during a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

Robert Wood Johnson Foundation (RWJF) Emergency Response for the General Public Innovation Challenge
Funding amount: unspecified
Application deadline: June 12, 2020, by 11:59 pm ET (Phase I Deadline:); August 18, 2020, by 11:59 pm ET (Phase II Deadline)
Can you build a health technology tool to support the needs of individuals affected by a large-scale health crisis (pandemic, natural disaster, or other public health emergency)?

RFA-HS-20-003 Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 (R01)
Funding amount: up to $500K per year for up to 2 years
Application deadline: June 15, 2020, by 5 pm local time
AHRQ is interested in funding critical research focused on evaluating topics such as effects on quality, safety, and value of health system response to COVID-19; the role of primary care practices and professionals during the COVID-19 epidemic; understanding how the response to COVID-19 affected socially vulnerable populations and people with multiple chronic conditions; and digital healthcare including innovations and challenges encountered in the rapid expansion of telehealth response to COVID-19. AHRQ encourages multi-method, rapid-cycle research with the ability to: produce and disseminate initial findings (e.g. observations, lessons learned, or findings) within 6 months after award and then regularly throughout the remainder of the award period.

Pfizer: Vaccine Preventable Diseases – COVID-19 Competitive Grant Program
Funding amount: from $50K to $250K per grant
Application deadline: Rolling with firm deadline of June 17, 2020, by 11:59 pm ET
The purpose of this RFP is to support research to increase knowledge of COVID-19 epidemiology, infection, pathophysiology, and potential prevention measures. We are particularly interested in supporting research in the following areas: (1) understand impact of COVID on communities, spectrum of disease in communities, and level of herd immunity; (2) Postmortem Analysis of deceased persons with known or suspected COVID-19. 

Healthy Eating Research: Special Call for COVID-19 Related Projects Focused on the Federal Nutrition Assistance Programs
Funding amount: from $3K to $8K (for Issue Briefs/Commentaries and Papers/Research Reviews); up to $50K (for Small Studies)
Application deadline: July 1, 2020, or until all available funds have been commissioned
Healthy Eating Research, a national program of the Robert Wood Johnson Foundation, has a limited amount of rapid-response research funds available to commission: 1) issue briefs/ commentaries or papers/research reviews and; 2) small studies to explore the impact of the coronavirus pandemic on nutrition and diet quality, food security, and related health consequences for children and families. This funding opportunity is focused on USDA Federal Nutrition Assistance Programs serving children and families. The goal is to inform decision-making regarding innovative policies and/or programs during and after the COVID-19 pandemic. 

Institution of Engineering and Technology E&T Innovation Awards - Small idea, Big impact: Global Challenge
Funding amount: varies
Application deadline: July 3, 2020
Previously known as the IET Innovation Awards, we are excited to announce that this year we have rebranded the Awards as the E&T Innovation Awards. Covid-19 has paved the way for new collaborations and out-of-the-box thinking. We would like to celebrate the innovators who have found new ways to support the government, society and individuals who need help during the coronavirus (COVID-19) outbreak. No matter how small or big your innovation, we want to hear from you.

The Bridge Ahead Initiative
Funding amount: total budget is $5M; Phase 1 supports development of digital or print strategies to engage and connect with partner communities remotely while museums are shuttered; Phase 2 provides support as museums prepare for reopening
Application deadline: Applications will be accepted on a rolling basis beginning Monday, May 11, and will continue until all funds are disbursed
Art Bridges recognizes the unprecedented financial challenges resulting from the COVID-19 pandemic and museum closures. In an effort to support our partners during these uncertain times, Art Bridges is launching the Bridge Ahead Initiative to help our partner museums remain in touch with their audiences during this period and to prepare for reopening in the months ahead.

FUNDING AND DATA RESOURCES FOR COVID19 REPURPOSING​

NIAID -- NOT-AI-20-051, NOSI: Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
First available on: June 16, 2020; Expires on: September 8, 2021
This NOSI replaces NOT-AI-20-031, which was expired following the release of two FOAs that provide an expedited funding mechanism for research on SARS-CoV-2 and COVID-19 using the R01 and R21 funding mechanisms:
-Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed); and
-Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)

Help Inform Research Strategy for Coronavirus Serology Testing
Through the Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences, NCI is soliciting community feedback on two research topics related to serology: (1) Research about the relationship between immunity, recent infection, antibody production, and other immunological markers, and (2) Clinical utilization of serological testing. The RFI invites your comments on research approaches for these topics. To send feedback, email Serology_RFI@mail.nih.gov, indicate “RFI Response” in the subject line of your email and include a reference to NOT-CA-20-065. The deadline to respond is May 26, 2020, at 11:59 pm ET.

Check Out New NIH Resources for COVID-19 Surveys, Publications
NIH created two new resources for researchers studying SARS-CoV-2 and COVID-19. The first indexes COVID-19 research and the second compiles COVID-19 survey data.

1. The COVID-19 Portfolio is a repository from NIH’s Office of Portfolio Analysis (OPA) that contains expert-curated, peer-reviewed articles from PubMed and preprints from arXiv, medRxiv, bioRxiv, ChemRxiv, SSRN, and Research Square. Investigators can use the repository to analyze research and data in real time.
2. COVID-19 Survey Platforms - Two NIH-supported survey item platforms help collate and standardize COVID-19 related survey items and investigator contact information: NIH Public Health Emergency and Disaster Research Response (DR2) and PhenX Toolkit.

COVID-19 Open Research Dataset Challenge (CORD-19)In response to the COVID-19 pandemic, the White House and a coalition of leading research groups have prepared the COVID-19 Open Research Dataset (CORD-19). CORD-19 is a resource of over 128,000 scholarly articles, including over 59,000 with full text, about COVID-19, SARS-CoV-2, and related coronaviruses. This freely available dataset is provided to the global research community to apply recent advances in natural language processing and other AI techniques to generate new insights in support of the ongoing fight against this infectious disease. 

Argonne National Lab: Expedited, Rapid Access Call for COVID-19 Research
The APS is providing expedited remote access for research related to COVID-19 at this time. The Structural Biology Portal lists available APS beamlines for macromolecular crystallography and BioSAXS. Step-by-step instructions on how to apply for expedited beam time are listed on the New User Checklist. All users must be registered and their home institution must have an active User Agreement.

COVID-19 Collaboration Platform offers central site for sharing clinical trial protocols
More than 400 randomized clinical trials have been registered on clinicaltrials.gov. Many aim to answer similar questions but lack any method to combine data. By aggregating evidence across these trials, we can learn about interventions for COVID-19 as quickly and reliably as possible. The COVID-19 Collaboration Platform (CovidCP) brings unassociated research teams working on the same clinical research questions together to share protocols, data, and evidence.

CovidCP offers support managing collaborations, including expedited and prioritized help from the Trial Innovation Network and SMART IRB to form multi-site trials; expert statistical advice for aggregated analyses, and free data storage and anonymization through vivli.org. It is a partnership among over a dozen research institutions, including CTSA hubs.

North American Meetings of the Regional Science Association International (RSAI) CFP: Special Session(s) Covid-19 (Coronavirus) - Regional Drivers, Effects, and Policy Responses
When/Where: San Diego, CA – November 11-14, 2020 
If you are interested in presenting your research in this special session, please submit an abstract (2,000 to 5,500 characters and spaces) through the conference portal. Upon submitting your abstract, you will receive an abstract ID number (e.g. P12345). Please send your abstract ID number and a copy of your abstract to Neil Reid (neil.reid@utoledo.edu) no later than June 20, 2020. 

Need COVID-19 Data? Request support
If you are pursuing a project that requires COVID-19 data, the Biomedical Informatics Core can help you access data from the UI Health System and other institutions nationwide.

Need to organize your data? Get a REDCap account. Need to analyze your data? Talk to a biostatistician.

The following websites share a variety of COVID-19 related RFAs:

U.S. Centers for Disease Control,   U.S. National Institutes of Health and Pivot Covid-19 Opportunities

NEWSWIRE

New remdesivir trial at UIC tests drug in combination with baricitinib
The University of Illinois at Chicago is enrolling patients in a second clinical trial to study the drug remdesivir as a treatment for COVID-19. Funded by NIAID, this international randomized, placebo-controlled clinical trial will study the antiviral drug in combination with an anti-inflammatory drug used to treat rheumatoid arthritis called baricitinib. This trial follows the NIAID’s Adaptive COVID-19 Treatment Trial in which results showed that patients who were treated with remdesivir recovered faster than those who were in the control group and received a placebo.

U of I Board of Trustees Chair commits $100K for UIC’s frontline health care workers
U of I Board of Trustees Chairman Don Edwards and his wife, Anne Edwards, both alumni of the University of Illinois, have pledged $100K to establish the UI Health Employee Relief Fund, which will support health care workers at UI Health. 

Making a homemade COVID mask? UI Study explains best fabric choices
Grainger College of Engineering Mechanical science and engineering prof. Taher Saif spoke with News Bureau physical sciences editor Lois Yoksoulian about a study that he and his graduate students performed on the effectiveness of common household fabrics for use in homemade masks.

Moderna Coronavirus Vaccine Trial Shows Promising Early Results
The company said a test in 8 healthy volunteers found its experimental vaccine was safe and provoked a strong immune response. It is on an accelerated timetable to begin larger human trials soon.

Llama Antibodies Neutralize Virus That Causes COVID-19, New Research Shows
Scientists are pursuing multiple tracks of research in the quest for an effective treatment to combat the COVID-19 pandemic. One pathway showing some early promise involves llamas. A new study shows that antibodies from llamas can neutralize the virus that causes COVID-19.

Social distancing a week earlier could have saved 36,000 US lives, study finds
Had the US begun social distancing just one week earlier, the country would have prevented 36,000 deaths through early May, according to researchers at Columbia U.

Coronavirus Commission on Safety and Quality in Nursing Homes - Call for nominations
CMS is launching an independent commission to conduct a comprehensive assessment of the nursing home response to the COVID-19 pandemic. This assessment will inform efforts to safeguard the health and quality of life of vulnerable Americans as CMS continues to battle COVID-19, as well as prepare for future threats to resident safety and public health. Nominations for the commission can be submitted through Friday, May 22, 2020.

Supplemental Appropriations Bolster NIAID's COVID-19 Response
This spring, NIAID received a total of $1.532B from Congress to support our research response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). For perspective, NIAID's annual appropriation for FY 2020 was $5.885B.

HHS Provides $225M for COVID-19 Testing in Rural Communities
On May 20, the USDHHS, through the Health Resources and Services Administration (HRSA) provided $225M to Rural Health Clinics (RHCs) for COVID-19 testing.  These investments will support over 4,500 RHCs across the country to support COVID-19 testing efforts and expand access to testing in rural communities. 

HHS Awards $15M to Support Telehealth Providers During the COVID-19 Pandemic
On May 13, the USDHHS, through the HRSA awarded $15M to 159 organizations across five health workforce programs to increase telehealth capabilities in response to the COVID-19 pandemic. These awards demonstrate the Trump Administration’s continued efforts and commitment to building a national telehealth infrastructure.

 
 
 
 
 

Subscribe   Unsubscribe